STERLING DEESIDE LIMITED
STERLING DEESIDE LIMITED is a private limited company registered in the United Kingdom, under 07235280, incorporated on 26 April 2010. The company is currently active. Operates in the research and experimental development on biotechnology sector (SIC 72110). The company has been operating for 16 years. Registered office address: CH5 2UA Deeside, the United Kingdom. Formerly known as ADC BIOTECHNOLOGY LIMITED. Directors include MR MATTHEW DAVID ANDERSON and MR KARL ROTTHIER. Sole shareholder is STERLING PHARMA SOLUTIONS LIMITED. Associated with 6 related entities, including SAFFRON NEWCO LIMITED, STERLING NEWCASTLE LIMITED, and STERLING PHARMA SOLUTIONS LIMITED. No sanctions, PEP status, or adverse risk signals are currently on record. Data sourced from UK Companies House.
Official Identifiers
Name Registry
ADC BIOTECHNOLOGY LIMITED
REAXA BIOTECH LTD
Registered Address
UNIT 103 TENTH AVENUE
DEESIDE INDUSTRIAL PARK
CH5 2UA DEESIDE
the United Kingdom
Signal Intelligence
No sanctions, PEP status, or adverse risk signals are currently on record for this entity.
Key Management & Controllers
Associated Entities
Companies sharing one or more directors or officers with this entity.
Change Log (1)
| Date | Change | Details |
|---|---|---|
| 2026-05-07 | DIRECTOR ADDED | Septima Maguire (director) |
Source Records (1)
| companieshouse | 07235280 | 2026-06-01 | open_in_new |